Non-Incised Papilla Flap in Deep Supraossous Defects
Launched by AIN SHAMS UNIVERSITY · May 9, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new surgical technique called the Non-Incised Papilla Flap (NIPSA) to treat deep periodontal defects caused by periodontitis, which is a serious gum disease. The goal is to see how effective this technique is compared to traditional methods. NIPSA allows the dentist to access the affected area from a different angle, which may lead to better healing and results for patients with these types of gum issues.
To participate in this trial, individuals must be diagnosed with advanced periodontitis and have certain conditions in their mouth that haven’t improved with previous treatments. Eligible participants include non-smokers or those who have quit smoking for at least a year, and they should have completed initial non-surgical treatments for their gum disease. Participants can expect to undergo the new surgical procedure and be monitored closely during their recovery to assess how well it works. This trial is currently recruiting patients of all genders aged between 58 and 43. If you're considering participating, it's important to discuss your specific situation with your dentist to see if you meet the criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of periodontal disease (periodontitis stage III and IV, grade A \[12\];
- • non-smokers and former smokers who quit smoking at least 1 year previously
- • previous treatment for periodontal disease using non-surgical periodontal treatment completion of step I and II of periodontal therapy
- • compliance with periodontal maintenance and oral hygiene (FMPS at baseline ≤ 30%)
- • active residual pockets (positive bleeding on probing; BoP) associated with intrabony defects that were not resolved with non-surgical treatment after 4-6 months of maintenance.
- • periodontal lesions with probing depth (PD) \> 6 mm and supraalveolar defect (pre-diagnosis clinically (periodontal probe)
- Exclusion Criteria:
- • systemic disease contraindicating periodontal surgery,
- • smokers, and
- • third molars or teeth with incorrect
- • endodontic or restorative treatment.
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Al Qahirah, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported